Dynavax Technologies Corp (DVAX)
12.36
+0.19
(+1.56%)
USD |
NASDAQ |
Nov 21, 16:00
12.38
+0.02
(+0.12%)
After-Hours: 20:00
Dynavax Technologies Debt to Equity Ratio: 0.3281 for Sept. 30, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| September 30, 2024 | 0.3281 |
| June 30, 2024 | 0.3473 |
| March 31, 2024 | 0.3605 |
| December 31, 2023 | 0.358 |
| September 30, 2023 | 0.3677 |
| June 30, 2023 | 0.3848 |
| March 31, 2023 | 0.3935 |
| December 31, 2022 | 0.3814 |
| September 30, 2022 | 0.4421 |
| June 30, 2022 | 0.5228 |
| March 31, 2022 | 0.7679 |
| December 31, 2021 | 0.9915 |
| September 30, 2021 | 3.259 |
| June 30, 2021 | 2.638 |
| March 31, 2021 | 1.803 |
| December 31, 2020 | 3.064 |
| September 30, 2020 | 2.594 |
| June 30, 2020 | 3.082 |
| March 31, 2020 | 15.19 |
| December 31, 2019 | 21.54 |
| September 30, 2019 | 4.536 |
| June 30, 2019 | 16.68 |
| March 31, 2019 | 4.070 |
| December 31, 2018 | 1.600 |
| September 30, 2018 | 1.034 |
| Date | Value |
|---|---|
| June 30, 2018 | 0.7598 |
| March 31, 2018 | 0.5982 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.1269 |
| March 31, 2015 | 0.1266 |
| December 31, 2014 | 0.0951 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
| December 31, 2013 | 0.00 |
| September 30, 2013 | 0.00 |
| June 30, 2013 | 0.00 |
| March 31, 2013 | 0.00 |
| December 31, 2012 | 0.00 |
| September 30, 2012 | 0.1111 |
| June 30, 2012 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
0.3281
Minimum
Sep 2024
21.54
Maximum
Dec 2019
2.941
Average
0.6454
Median
Debt to Equity Ratio Benchmarks
| Biogen Inc | 0.3847 |
| Repligen Corp | 0.2586 |
| West Pharmaceutical Services Inc | 0.0736 |
| Janux Therapeutics Inc | 0.00 |
| XOMA Royalty Corp | 1.390 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 1.062B |
| Total Liabilities (Quarterly) | 380.56M |
| Shareholders Equity (Quarterly) | 681.43M |
| Current Ratio | 13.23 |
| Net Debt Paydown Yield | -0.02% |